Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bipolar Disorder | 143 | 2024 | 5027 | 10.000 |
Why?
|
Lithium | 37 | 2024 | 601 | 4.750 |
Why?
|
Depressive Disorder, Major | 41 | 2023 | 4639 | 3.570 |
Why?
|
Suicide | 29 | 2023 | 1474 | 3.170 |
Why?
|
Antimanic Agents | 29 | 2021 | 522 | 2.940 |
Why?
|
Lithium Compounds | 19 | 2022 | 225 | 2.800 |
Why?
|
Mood Disorders | 18 | 2022 | 1106 | 2.640 |
Why?
|
Suicide, Attempted | 33 | 2022 | 1218 | 2.640 |
Why?
|
Antidepressive Agents | 47 | 2024 | 2838 | 2.410 |
Why?
|
Temperament | 14 | 2023 | 283 | 1.910 |
Why?
|
Suicidal Ideation | 11 | 2023 | 1246 | 1.780 |
Why?
|
Italy | 26 | 2021 | 832 | 1.390 |
Why?
|
Psychotropic Drugs | 7 | 2022 | 894 | 1.210 |
Why?
|
Lithium Carbonate | 12 | 2010 | 184 | 1.110 |
Why?
|
Antipsychotic Agents | 16 | 2024 | 3057 | 1.080 |
Why?
|
Depressive Disorder | 22 | 2020 | 3747 | 1.070 |
Why?
|
Anxiety Disorders | 11 | 2022 | 2690 | 0.960 |
Why?
|
Cyclothymic Disorder | 3 | 2014 | 41 | 0.900 |
Why?
|
Electroconvulsive Therapy | 7 | 2016 | 477 | 0.870 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 12 | 2023 | 1953 | 0.720 |
Why?
|
Depression | 16 | 2022 | 7759 | 0.710 |
Why?
|
Appetite | 1 | 2022 | 243 | 0.710 |
Why?
|
Age of Onset | 14 | 2022 | 3270 | 0.620 |
Why?
|
Psychopharmacology | 1 | 2019 | 143 | 0.590 |
Why?
|
Transients and Migrants | 1 | 2020 | 155 | 0.590 |
Why?
|
Psychiatry | 4 | 2018 | 1695 | 0.590 |
Why?
|
Anticonvulsants | 9 | 2024 | 1916 | 0.580 |
Why?
|
Antidepressive Agents, Tricyclic | 3 | 2020 | 434 | 0.560 |
Why?
|
Argentina | 7 | 2020 | 232 | 0.550 |
Why?
|
Humans | 196 | 2024 | 744366 | 0.530 |
Why?
|
Psychotic Disorders | 6 | 2018 | 3046 | 0.490 |
Why?
|
Menarche | 1 | 2016 | 516 | 0.470 |
Why?
|
Drug Therapy | 1 | 2016 | 497 | 0.450 |
Why?
|
Borderline Personality Disorder | 1 | 2020 | 736 | 0.440 |
Why?
|
Adult | 87 | 2022 | 214052 | 0.430 |
Why?
|
Micronutrients | 1 | 2015 | 375 | 0.430 |
Why?
|
Personality Inventory | 6 | 2022 | 1030 | 0.430 |
Why?
|
Weight Gain | 1 | 2022 | 2293 | 0.400 |
Why?
|
Risk Factors | 42 | 2023 | 72296 | 0.400 |
Why?
|
Internationality | 5 | 2019 | 1002 | 0.390 |
Why?
|
Reproductive Behavior | 1 | 2011 | 29 | 0.380 |
Why?
|
Psychiatric Status Rating Scales | 15 | 2017 | 6036 | 0.380 |
Why?
|
Emigrants and Immigrants | 1 | 2017 | 522 | 0.370 |
Why?
|
Birth Rate | 1 | 2011 | 170 | 0.350 |
Why?
|
Irritable Mood | 3 | 2021 | 183 | 0.350 |
Why?
|
Female | 103 | 2024 | 380193 | 0.350 |
Why?
|
Substance Withdrawal Syndrome | 10 | 2010 | 632 | 0.350 |
Why?
|
Male | 99 | 2023 | 350115 | 0.340 |
Why?
|
Siblings | 1 | 2013 | 854 | 0.340 |
Why?
|
Mental Disorders | 4 | 2019 | 6598 | 0.330 |
Why?
|
Selection, Genetic | 1 | 2013 | 914 | 0.320 |
Why?
|
Seasons | 5 | 2022 | 1493 | 0.310 |
Why?
|
Sex Distribution | 4 | 2020 | 2297 | 0.300 |
Why?
|
Multivariate Analysis | 8 | 2015 | 12244 | 0.290 |
Why?
|
Sex Factors | 19 | 2019 | 10400 | 0.290 |
Why?
|
Treatment Outcome | 40 | 2019 | 63107 | 0.280 |
Why?
|
Comorbidity | 11 | 2018 | 10388 | 0.280 |
Why?
|
Prevalence | 13 | 2020 | 15221 | 0.280 |
Why?
|
Puerperal Disorders | 3 | 2023 | 275 | 0.280 |
Why?
|
Family Characteristics | 1 | 2011 | 1000 | 0.270 |
Why?
|
Age Distribution | 3 | 2020 | 2902 | 0.260 |
Why?
|
History, 19th Century | 3 | 2018 | 720 | 0.260 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 3 | 2018 | 3658 | 0.250 |
Why?
|
Health Personnel | 1 | 2018 | 3219 | 0.250 |
Why?
|
Substance-Related Disorders | 8 | 2019 | 4257 | 0.240 |
Why?
|
Middle Aged | 53 | 2019 | 213390 | 0.230 |
Why?
|
Anxiety | 4 | 2022 | 4293 | 0.230 |
Why?
|
Sunlight | 3 | 2022 | 325 | 0.230 |
Why?
|
Drug Therapy, Combination | 12 | 2021 | 6489 | 0.220 |
Why?
|
Cross-Cultural Comparison | 3 | 2020 | 651 | 0.220 |
Why?
|
Morbidity | 4 | 2021 | 1768 | 0.220 |
Why?
|
Drug Administration Schedule | 14 | 2010 | 4933 | 0.210 |
Why?
|
Recurrence | 23 | 2015 | 8340 | 0.210 |
Why?
|
Clinical Trials as Topic | 6 | 2014 | 7914 | 0.190 |
Why?
|
Valproic Acid | 2 | 2021 | 445 | 0.190 |
Why?
|
History, 20th Century | 4 | 2018 | 2740 | 0.190 |
Why?
|
Randomized Controlled Trials as Topic | 13 | 2022 | 9955 | 0.170 |
Why?
|
Survival Analysis | 10 | 2022 | 10252 | 0.170 |
Why?
|
Schizophrenia | 3 | 2015 | 6882 | 0.160 |
Why?
|
History, Medieval | 1 | 2018 | 63 | 0.160 |
Why?
|
Severity of Illness Index | 10 | 2020 | 15535 | 0.160 |
Why?
|
Paranoid Disorders | 1 | 2018 | 60 | 0.160 |
Why?
|
History, 17th Century | 1 | 2018 | 111 | 0.150 |
Why?
|
Schizophrenia, Paranoid | 1 | 2018 | 104 | 0.150 |
Why?
|
History, Ancient | 1 | 2018 | 212 | 0.150 |
Why?
|
Scopolamine | 3 | 1997 | 99 | 0.150 |
Why?
|
Cities | 1 | 2020 | 513 | 0.150 |
Why?
|
Medication Adherence | 1 | 2008 | 2063 | 0.150 |
Why?
|
Interview, Psychological | 2 | 2011 | 812 | 0.150 |
Why?
|
Demography | 2 | 2015 | 1655 | 0.150 |
Why?
|
Age Factors | 10 | 2019 | 18373 | 0.140 |
Why?
|
History, 18th Century | 1 | 2017 | 213 | 0.140 |
Why?
|
Time Factors | 21 | 2015 | 40075 | 0.140 |
Why?
|
Self-Help Groups | 1 | 2017 | 190 | 0.130 |
Why?
|
Benzodiazepines | 3 | 2021 | 1101 | 0.130 |
Why?
|
Longitudinal Studies | 8 | 2022 | 13991 | 0.130 |
Why?
|
Delusions | 1 | 2018 | 300 | 0.130 |
Why?
|
Brazil | 1 | 2020 | 1270 | 0.130 |
Why?
|
Psychometrics | 7 | 2018 | 3003 | 0.130 |
Why?
|
Ketamine | 2 | 2021 | 501 | 0.130 |
Why?
|
Adolescent | 17 | 2022 | 85779 | 0.120 |
Why?
|
Behavioral Symptoms | 1 | 2016 | 175 | 0.120 |
Why?
|
Internet | 2 | 2017 | 3056 | 0.120 |
Why?
|
Memantine | 1 | 2015 | 100 | 0.120 |
Why?
|
Personality | 2 | 2011 | 552 | 0.120 |
Why?
|
MMPI | 2 | 1991 | 86 | 0.120 |
Why?
|
Follow-Up Studies | 16 | 2018 | 39052 | 0.120 |
Why?
|
Logistic Models | 4 | 2018 | 13409 | 0.120 |
Why?
|
Circadian Rhythm | 4 | 2022 | 2624 | 0.110 |
Why?
|
Thyrotropin-Releasing Hormone | 1 | 1993 | 147 | 0.110 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2014 | 187 | 0.110 |
Why?
|
Patient Dropouts | 2 | 2014 | 420 | 0.110 |
Why?
|
Secondary Prevention | 7 | 2010 | 1530 | 0.110 |
Why?
|
Probiotics | 1 | 2017 | 351 | 0.110 |
Why?
|
Imipramine | 1 | 2012 | 97 | 0.110 |
Why?
|
ROC Curve | 3 | 2019 | 3528 | 0.110 |
Why?
|
Risk Adjustment | 1 | 2016 | 594 | 0.110 |
Why?
|
Monoamine Oxidase Inhibitors | 1 | 2012 | 158 | 0.110 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2015 | 449 | 0.110 |
Why?
|
Personality Assessment | 2 | 2011 | 647 | 0.100 |
Why?
|
Disease Susceptibility | 1 | 1999 | 1782 | 0.100 |
Why?
|
Retrospective Studies | 13 | 2022 | 77460 | 0.100 |
Why?
|
Young Adult | 9 | 2022 | 56429 | 0.100 |
Why?
|
Ejaculation | 1 | 1991 | 58 | 0.100 |
Why?
|
Fluoxetine | 1 | 2015 | 749 | 0.100 |
Why?
|
Family Health | 2 | 2015 | 1281 | 0.100 |
Why?
|
Panic Disorder | 2 | 2014 | 616 | 0.090 |
Why?
|
Gene Products, rev | 1 | 2010 | 31 | 0.090 |
Why?
|
Prospective Studies | 12 | 2023 | 53290 | 0.090 |
Why?
|
Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2010 | 32 | 0.090 |
Why?
|
Placebo Effect | 1 | 2014 | 502 | 0.090 |
Why?
|
Causality | 1 | 2016 | 1275 | 0.090 |
Why?
|
Risk Assessment | 9 | 2014 | 23336 | 0.090 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 1991 | 187 | 0.090 |
Why?
|
Child | 11 | 2022 | 77709 | 0.090 |
Why?
|
Thyrotropin | 1 | 1993 | 849 | 0.090 |
Why?
|
Panic | 1 | 1989 | 106 | 0.080 |
Why?
|
Sexuality | 1 | 2011 | 174 | 0.080 |
Why?
|
Fatty Acids | 1 | 2017 | 1809 | 0.080 |
Why?
|
Health Services Accessibility | 1 | 2006 | 5135 | 0.080 |
Why?
|
Physician-Patient Relations | 1 | 2022 | 3229 | 0.080 |
Why?
|
Europe | 4 | 2017 | 3338 | 0.080 |
Why?
|
Carbamazepine | 1 | 1989 | 229 | 0.080 |
Why?
|
Growth Hormone | 1 | 1991 | 705 | 0.080 |
Why?
|
Aged | 15 | 2020 | 163288 | 0.080 |
Why?
|
Hydrocortisone | 2 | 1993 | 1826 | 0.080 |
Why?
|
Psychotherapy | 2 | 2023 | 1642 | 0.080 |
Why?
|
Periodicity | 3 | 2000 | 364 | 0.070 |
Why?
|
Erectile Dysfunction | 1 | 1991 | 461 | 0.070 |
Why?
|
Affect | 2 | 2013 | 1475 | 0.070 |
Why?
|
Long-Term Care | 4 | 2007 | 607 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2017 | 1790 | 0.070 |
Why?
|
Ecology | 1 | 2007 | 106 | 0.070 |
Why?
|
Caffeine | 1 | 1991 | 699 | 0.070 |
Why?
|
Citalopram | 1 | 2009 | 403 | 0.070 |
Why?
|
Hospitalization | 4 | 2015 | 10259 | 0.070 |
Why?
|
Advisory Committees | 3 | 2015 | 775 | 0.070 |
Why?
|
Emotions | 1 | 2018 | 2659 | 0.070 |
Why?
|
Pindolol | 1 | 1985 | 32 | 0.070 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2009 | 503 | 0.070 |
Why?
|
Sleep | 2 | 1993 | 4622 | 0.070 |
Why?
|
Bayes Theorem | 1 | 2014 | 2307 | 0.070 |
Why?
|
Multicenter Studies as Topic | 1 | 2011 | 1677 | 0.070 |
Why?
|
Sleep, REM | 3 | 1997 | 595 | 0.070 |
Why?
|
Dexamethasone | 1 | 1993 | 1951 | 0.070 |
Why?
|
Fertility | 1 | 2011 | 781 | 0.070 |
Why?
|
Risk | 3 | 2010 | 9688 | 0.070 |
Why?
|
Exercise | 1 | 2022 | 5615 | 0.070 |
Why?
|
Population Density | 1 | 2006 | 196 | 0.070 |
Why?
|
Psychological Tests | 1 | 1988 | 651 | 0.070 |
Why?
|
Odds Ratio | 3 | 2010 | 9849 | 0.060 |
Why?
|
Censuses | 1 | 2006 | 200 | 0.060 |
Why?
|
Postpartum Period | 1 | 2011 | 1086 | 0.060 |
Why?
|
Receptors, Adrenergic, beta | 1 | 1985 | 246 | 0.060 |
Why?
|
Coffee | 1 | 2009 | 578 | 0.060 |
Why?
|
Cross-Sectional Studies | 5 | 2022 | 25039 | 0.060 |
Why?
|
Unemployment | 3 | 1991 | 214 | 0.060 |
Why?
|
Language | 1 | 2014 | 1471 | 0.060 |
Why?
|
Calcium Channels | 1 | 2008 | 622 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2023 | 12262 | 0.060 |
Why?
|
Socioeconomic Factors | 2 | 2009 | 7785 | 0.060 |
Why?
|
Placebos | 2 | 2006 | 1676 | 0.060 |
Why?
|
Stress, Psychological | 1 | 1999 | 4245 | 0.060 |
Why?
|
Pregnancy Complications | 2 | 2011 | 2861 | 0.050 |
Why?
|
Societies, Medical | 1 | 2014 | 3743 | 0.050 |
Why?
|
Financing, Government | 1 | 2006 | 468 | 0.050 |
Why?
|
Indians, North American | 1 | 2006 | 355 | 0.050 |
Why?
|
Drug Resistance | 1 | 2008 | 1608 | 0.050 |
Why?
|
Residence Characteristics | 1 | 2011 | 2050 | 0.050 |
Why?
|
Regression Analysis | 3 | 2010 | 6459 | 0.050 |
Why?
|
Meta-Analysis as Topic | 1 | 2006 | 1342 | 0.050 |
Why?
|
Fear | 1 | 1989 | 1440 | 0.050 |
Why?
|
Medically Uninsured | 1 | 2006 | 853 | 0.050 |
Why?
|
Pituitary-Adrenal System | 1 | 2023 | 553 | 0.040 |
Why?
|
Republic of Korea | 2 | 2011 | 538 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2021 | 10943 | 0.040 |
Why?
|
Prognosis | 8 | 2018 | 29060 | 0.040 |
Why?
|
Inpatients | 1 | 2011 | 2518 | 0.040 |
Why?
|
Incidence | 3 | 2015 | 20952 | 0.040 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2023 | 703 | 0.040 |
Why?
|
Lebanon | 2 | 2011 | 229 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14723 | 0.040 |
Why?
|
Factor Analysis, Statistical | 2 | 2014 | 977 | 0.040 |
Why?
|
Climate | 1 | 2019 | 147 | 0.040 |
Why?
|
Central Nervous System | 1 | 1985 | 1357 | 0.040 |
Why?
|
Solar System | 1 | 2017 | 12 | 0.040 |
Why?
|
Health Services Needs and Demand | 1 | 2006 | 1410 | 0.040 |
Why?
|
Electroencephalography | 1 | 1993 | 6151 | 0.040 |
Why?
|
Aggression | 1 | 2022 | 753 | 0.040 |
Why?
|
Personality Disorders | 2 | 2014 | 713 | 0.040 |
Why?
|
Cause of Death | 2 | 2006 | 3582 | 0.040 |
Why?
|
South America | 1 | 2017 | 181 | 0.040 |
Why?
|
Hospitals, Psychiatric | 1 | 1999 | 332 | 0.040 |
Why?
|
Sleep Stages | 2 | 1993 | 686 | 0.040 |
Why?
|
Income | 1 | 2006 | 1913 | 0.040 |
Why?
|
Muscarinic Antagonists | 1 | 1997 | 137 | 0.040 |
Why?
|
Receptors, Cholinergic | 1 | 1997 | 238 | 0.030 |
Why?
|
Asia | 1 | 2017 | 609 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2022 | 2715 | 0.030 |
Why?
|
Quality of Life | 1 | 2017 | 12802 | 0.030 |
Why?
|
Area Under Curve | 1 | 2019 | 1655 | 0.030 |
Why?
|
Africa | 1 | 2017 | 672 | 0.030 |
Why?
|
Preventive Psychiatry | 1 | 2014 | 6 | 0.030 |
Why?
|
Models, Statistical | 1 | 2009 | 5101 | 0.030 |
Why?
|
Epilepsy | 1 | 2010 | 3310 | 0.030 |
Why?
|
Australia | 1 | 2017 | 1167 | 0.030 |
Why?
|
Partial Thromboplastin Time | 1 | 1994 | 206 | 0.030 |
Why?
|
North America | 1 | 2017 | 1249 | 0.030 |
Why?
|
Urban Population | 1 | 2021 | 2022 | 0.030 |
Why?
|
Greece | 1 | 2014 | 344 | 0.030 |
Why?
|
Seasonal Affective Disorder | 1 | 1993 | 50 | 0.030 |
Why?
|
Episode of Care | 1 | 2013 | 126 | 0.030 |
Why?
|
Crime | 1 | 2014 | 215 | 0.030 |
Why?
|
Health Care Costs | 1 | 2006 | 3208 | 0.030 |
Why?
|
Smoking | 1 | 2009 | 8987 | 0.030 |
Why?
|
Syndrome | 1 | 1999 | 3252 | 0.030 |
Why?
|
United States | 5 | 2011 | 69872 | 0.030 |
Why?
|
Impulsive Behavior | 1 | 2014 | 316 | 0.030 |
Why?
|
Chlorpromazine | 1 | 1991 | 111 | 0.020 |
Why?
|
Delphi Technique | 1 | 2013 | 779 | 0.020 |
Why?
|
Personality Development | 1 | 1991 | 245 | 0.020 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2019 | 1004 | 0.020 |
Why?
|
Spain | 1 | 2011 | 465 | 0.020 |
Why?
|
Overweight | 1 | 2021 | 2371 | 0.020 |
Why?
|
Health Surveys | 2 | 2011 | 4036 | 0.020 |
Why?
|
Reference Standards | 1 | 2014 | 1025 | 0.020 |
Why?
|
Pregnancy | 4 | 2011 | 29144 | 0.020 |
Why?
|
Reproducibility of Results | 4 | 2014 | 19905 | 0.020 |
Why?
|
Cohort Studies | 2 | 2009 | 40559 | 0.020 |
Why?
|
Drug Combinations | 1 | 2015 | 1958 | 0.020 |
Why?
|
Haloperidol | 1 | 1991 | 397 | 0.020 |
Why?
|
Disease Progression | 2 | 2019 | 13286 | 0.020 |
Why?
|
Brain | 2 | 2015 | 26388 | 0.020 |
Why?
|
Agoraphobia | 1 | 1989 | 179 | 0.020 |
Why?
|
France | 1 | 2010 | 517 | 0.020 |
Why?
|
Research Design | 2 | 2004 | 5984 | 0.020 |
Why?
|
Rome | 1 | 2007 | 28 | 0.020 |
Why?
|
Patient Care Planning | 1 | 2013 | 921 | 0.020 |
Why?
|
International Cooperation | 1 | 2014 | 1420 | 0.020 |
Why?
|
Patient Selection | 1 | 2000 | 4216 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2006 | 5321 | 0.020 |
Why?
|
Translations | 1 | 2007 | 64 | 0.020 |
Why?
|
Physicians | 1 | 2006 | 4567 | 0.020 |
Why?
|
Dysthymic Disorder | 1 | 2007 | 74 | 0.020 |
Why?
|
Reaction Time | 2 | 1997 | 2098 | 0.020 |
Why?
|
Medical Records Systems, Computerized | 1 | 2013 | 1205 | 0.020 |
Why?
|
Pharmacoepidemiology | 1 | 2010 | 323 | 0.020 |
Why?
|
Betaxolol | 1 | 1985 | 1 | 0.020 |
Why?
|
Alprenolol | 1 | 1985 | 8 | 0.020 |
Why?
|
Clenbuterol | 1 | 1985 | 9 | 0.020 |
Why?
|
Propanolamines | 1 | 1985 | 167 | 0.020 |
Why?
|
Peer Review | 1 | 2007 | 209 | 0.020 |
Why?
|
Self Report | 1 | 2016 | 3553 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2010 | 764 | 0.020 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2005 | 295 | 0.020 |
Why?
|
Outpatients | 1 | 2012 | 1487 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2009 | 2274 | 0.020 |
Why?
|
Drug Approval | 1 | 2011 | 742 | 0.020 |
Why?
|
Genotype | 2 | 2010 | 12952 | 0.020 |
Why?
|
Consensus | 1 | 2013 | 2960 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2007 | 940 | 0.020 |
Why?
|
Mathematics | 1 | 1985 | 728 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1985 | 2186 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1985 | 1157 | 0.010 |
Why?
|
International Classification of Diseases | 1 | 2009 | 867 | 0.010 |
Why?
|
Isotope Labeling | 1 | 1985 | 406 | 0.010 |
Why?
|
Propranolol | 1 | 1985 | 502 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2011 | 1504 | 0.010 |
Why?
|
Linear Models | 1 | 2014 | 5953 | 0.010 |
Why?
|
Genetic Markers | 1 | 2010 | 2634 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2887 | 0.010 |
Why?
|
Liver Transplantation | 1 | 1994 | 2119 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 2 | 2018 | 17446 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16367 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 2008 | 1997 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3508 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2009 | 2373 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1991 | 6366 | 0.010 |
Why?
|
Checklist | 1 | 2009 | 833 | 0.010 |
Why?
|
Patient Admission | 1 | 2009 | 1380 | 0.010 |
Why?
|
Administration, Oral | 1 | 2009 | 3914 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1985 | 2327 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 2010 | 12356 | 0.010 |
Why?
|
Employment | 1 | 1987 | 1132 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2011 | 2585 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2006 | 2971 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 1991 | 2575 | 0.010 |
Why?
|
Brain Stem | 1 | 1985 | 846 | 0.010 |
Why?
|
Animals | 3 | 2021 | 168768 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2010 | 4328 | 0.010 |
Why?
|
Alleles | 1 | 2010 | 6933 | 0.010 |
Why?
|
Cerebellum | 1 | 1985 | 1488 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 7730 | 0.010 |
Why?
|
Spinal Cord | 1 | 1985 | 1810 | 0.010 |
Why?
|
Gene Expression | 1 | 2008 | 7798 | 0.010 |
Why?
|
Genetic Variation | 1 | 2010 | 6542 | 0.010 |
Why?
|
Affective Symptoms | 1 | 1976 | 407 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2008 | 13035 | 0.010 |
Why?
|
Informed Consent | 1 | 1999 | 995 | 0.010 |
Why?
|
Polysomnography | 1 | 1997 | 1776 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2008 | 21748 | 0.010 |
Why?
|
Postoperative Period | 1 | 1994 | 1842 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 1985 | 5709 | 0.010 |
Why?
|
Rats | 1 | 1985 | 24252 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2008 | 15520 | 0.010 |
Why?
|
Receptors, Muscarinic | 1 | 1989 | 156 | 0.010 |
Why?
|
Probability | 1 | 1993 | 2506 | 0.000 |
Why?
|
Hypochondriasis | 1 | 1987 | 92 | 0.000 |
Why?
|
Erythrocytes | 1 | 1976 | 2455 | 0.000 |
Why?
|
Terminology as Topic | 1 | 1993 | 1547 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 2000 | 15078 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1997 | 12025 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2008 | 57776 | 0.000 |
Why?
|
Ambulatory Care | 1 | 1993 | 2708 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1993 | 12961 | 0.000 |
Why?
|
Remission, Spontaneous | 1 | 1977 | 382 | 0.000 |
Why?
|
Drug Interactions | 1 | 1981 | 1460 | 0.000 |
Why?
|
Functional Laterality | 1 | 1977 | 2290 | 0.000 |
Why?
|